494 related articles for article (PubMed ID: 28437520)
1. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
2. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Schmidt B; Anderson PJ; Doyle LW; Dewey D; Grunau RE; Asztalos EV; Davis PG; Tin W; Moddemann D; Solimano A; Ohlsson A; Barrington KJ; Roberts RS;
JAMA; 2012 Jan; 307(3):275-82. PubMed ID: 22253394
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
4. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
Mürner-Lavanchy IM; Doyle LW; Schmidt B; Roberts RS; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W; Anderson PJ;
Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
[TBL] [Abstract][Full Text] [Related]
5. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.
Doyle LW; Ranganathan S; Cheong JLY
Am J Respir Crit Care Med; 2017 Nov; 196(10):1318-1324. PubMed ID: 28707987
[TBL] [Abstract][Full Text] [Related]
7. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
[TBL] [Abstract][Full Text] [Related]
8. Neurodevelopmental outcomes after neonatal caffeine therapy.
Synnes A; Grunau RE
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
[TBL] [Abstract][Full Text] [Related]
9. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Eichenwald EC
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
[TBL] [Abstract][Full Text] [Related]
10. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
Erenberg A; Leff RD; Haack DG; Mosdell KW; Hicks GM; Wynne BA
Pharmacotherapy; 2000 Jun; 20(6):644-52. PubMed ID: 10853619
[TBL] [Abstract][Full Text] [Related]
11. Caffeine citrate therapy for apnea of prematurity.
Johnson PJ
Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
[No Abstract] [Full Text] [Related]
12. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
Winckworth LC; Powell E
Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
[No Abstract] [Full Text] [Related]
13. On the caffeination of prematurity.
Stevenson DK
N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
[No Abstract] [Full Text] [Related]
14. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
Marcus CL; Meltzer LJ; Roberts RS; Traylor J; Dix J; D'ilario J; Asztalos E; Opie G; Doyle LW; Biggs SN; Nixon GM; Narang I; Bhattacharjee R; Davey M; Horne RS; Cheshire M; Gibbons J; Costantini L; Bradford R; Schmidt B;
Am J Respir Crit Care Med; 2014 Oct; 190(7):791-9. PubMed ID: 25171195
[TBL] [Abstract][Full Text] [Related]
15. Caffeine for apnea of prematurity: a neonatal success story.
Kreutzer K; Bassler D
Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
[TBL] [Abstract][Full Text] [Related]
16. Reduction in developmental coordination disorder with neonatal caffeine therapy.
Doyle LW; Schmidt B; Anderson PJ; Davis PG; Moddemann D; Grunau RE; O'Brien K; Sankaran K; Herlenius E; Roberts R;
J Pediatr; 2014 Aug; 165(2):356-359.e2. PubMed ID: 24840756
[TBL] [Abstract][Full Text] [Related]
17. Caffeine citrate: when and for how long. A literature review.
Picone S; Bedetta M; Paolillo P
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
[TBL] [Abstract][Full Text] [Related]
18. Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
Schmidt B; Roberts RS; Davis P; Doyle LW;
Arch Dis Child; 2011 Aug; 96(8):784. PubMed ID: 21377992
[No Abstract] [Full Text] [Related]
19. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
[TBL] [Abstract][Full Text] [Related]
20. Caffeine for apnea of prematurity.
Bancalari E
N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
